These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 25106448)
1. Polyploid giant cancer cells with budding and the expression of cyclin E, S-phase kinase-associated protein 2, stathmin associated with the grading and metastasis in serous ovarian tumor. Lv H; Shi Y; Zhang L; Zhang D; Liu G; Yang Z; Li Y; Fei F; Zhang S BMC Cancer; 2014 Aug; 14():576. PubMed ID: 25106448 [TBL] [Abstract][Full Text] [Related]
2. Number of polyploid giant cancer cells and expression of EZH2 are associated with VM formation and tumor grade in human ovarian tumor. Zhang L; Ding P; Lv H; Zhang D; Liu G; Yang Z; Li Y; Liu J; Zhang S Biomed Res Int; 2014; 2014():903542. PubMed ID: 25025074 [TBL] [Abstract][Full Text] [Related]
3. The subcellular location of cyclin B1 and CDC25 associated with the formation of polyploid giant cancer cells and their clinicopathological significance. Fei F; Qu J; Liu K; Li C; Wang X; Li Y; Zhang S Lab Invest; 2019 Apr; 99(4):483-498. PubMed ID: 30487595 [TBL] [Abstract][Full Text] [Related]
4. Association and clinicopathologic significance of p38MAPK-ERK-JNK-CDC25C with polyploid giant cancer cell formation. Liu K; Lu R; Zhao Q; Du J; Li Y; Zheng M; Zhang S Med Oncol; 2019 Nov; 37(1):6. PubMed ID: 31734829 [TBL] [Abstract][Full Text] [Related]
5. Different p53 genotypes regulating different phosphorylation sites and subcellular location of CDC25C associated with the formation of polyploid giant cancer cells. Liu K; Zheng M; Zhao Q; Zhang K; Li Z; Fu F; Zhang H; Du J; Li Y; Zhang S J Exp Clin Cancer Res; 2020 May; 39(1):83. PubMed ID: 32393310 [TBL] [Abstract][Full Text] [Related]
6. The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer. Fei F; Zhang D; Yang Z; Wang S; Wang X; Wu Z; Wu Q; Zhang S J Exp Clin Cancer Res; 2015 Dec; 34():158. PubMed ID: 26702618 [TBL] [Abstract][Full Text] [Related]
7. iTRAQ-based proteomic analysis of polyploid giant cancer cells and budding progeny cells reveals several distinct pathways for ovarian cancer development. Zhang S; Mercado-Uribe I; Hanash S; Liu J PLoS One; 2013; 8(11):e80120. PubMed ID: 24348907 [TBL] [Abstract][Full Text] [Related]
8. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances]. Hu YQ; Liu YJ Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212 [TBL] [Abstract][Full Text] [Related]
9. Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs). Bowers RR; Andrade MF; Jones CM; White-Gilbertson S; Voelkel-Johnson C; Delaney JR BMC Cancer; 2022 Apr; 22(1):410. PubMed ID: 35421971 [TBL] [Abstract][Full Text] [Related]
10. EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment. Wang X; Zheng M; Fei F; Li C; Du J; Liu K; Li Y; Zhang S Med Oncol; 2019 Aug; 36(9):82. PubMed ID: 31407170 [TBL] [Abstract][Full Text] [Related]
11. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors. Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733 [TBL] [Abstract][Full Text] [Related]
12. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors]. Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848 [TBL] [Abstract][Full Text] [Related]
13. Generation of Polyploid Giant Cancer Cells (PGCCs) from Hey Ovarian Cancer Cells and Analysis of Embryonic Properties. Niu N; Liu J Methods Mol Biol; 2024; 2825():281-292. PubMed ID: 38913316 [TBL] [Abstract][Full Text] [Related]
14. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study. Brunette LL; Mhawech-Fauceglia PY; Ji L; Skeate JG; Brand HE; Lawrenson K; Walia S; Chiriva-Internati M; Groshen S; Roman LD; Kast WM; Da Silva DM BMC Cancer; 2018 Oct; 18(1):970. PubMed ID: 30309325 [TBL] [Abstract][Full Text] [Related]
15. Daughter Cells and Erythroid Cells Budding from PGCCs and Their Clinicopathological Significances in Colorectal Cancer. Zhang D; Yang X; Yang Z; Fei F; Li S; Qu J; Zhang M; Li Y; Zhang X; Zhang S J Cancer; 2017; 8(3):469-478. PubMed ID: 28261349 [No Abstract] [Full Text] [Related]
16. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors. Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M Oncol Rep; 2006 Apr; 15(4):765-71. PubMed ID: 16525656 [TBL] [Abstract][Full Text] [Related]
17. Polyploid giant cancer cells induced by Docetaxel exhibit a senescence phenotype with the expression of stem cell markers in ovarian cancer cells. Zhao S; Wang L; Ouyang M; Xing S; Liu S; Sun L; Yu H PLoS One; 2024; 19(7):e0306969. PubMed ID: 38990953 [TBL] [Abstract][Full Text] [Related]
18. Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. Karst AM; Levanon K; Duraisamy S; Liu JF; Hirsch MS; Hecht JL; Drapkin R Gynecol Oncol; 2011 Oct; 123(1):5-12. PubMed ID: 21683992 [TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL; Shen DH; Xue WC; Li Y; Yu YZ Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [TBL] [Abstract][Full Text] [Related]
20. Syncytin 1, CD9, and CD47 regulating cell fusion to form PGCCs associated with cAMP/PKA and JNK signaling pathway. Fei F; Li C; Wang X; Du J; Liu K; Li B; Yao P; Li Y; Zhang S Cancer Med; 2019 Jun; 8(6):3047-3058. PubMed ID: 31025548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]